5-lipoxygenase inhibitor zileuton attenuates ischemic brain damage: Involvement of matrix metalloproteinase 9

Neurological Research

Volumn 31, Issue 8, 2009, Pages 848-852

  Tu, Xian Kun ^a   Yang, Wei Zhong ^a   Shi, Song Sheng ^a   Chen, Chun Mei ^a   Wang, Chun Hua ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

5 lipoxygenase; Cerebral ischemia; Matrix metalloproteinase 9; Neuroprotection; Zileuton

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; GELATINASE B; LIPOXYGENASE INHIBITOR; MESSENGER RNA; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; GLIOMA; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WATER CONTENT; ZYMOGRAPHY;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; BODY WATER; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HYDROXYUREA; INFARCTION, MIDDLE CEREBRAL ARTERY; LIPOXYGENASE INHIBITORS; MALE; MATRIX METALLOPROTEINASE 9; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 69249144781     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X403913     Document Type: Article

References (25)

1. Osher E, Weisinger G, Limor R, et al. The 5-lipoxygenase system in the vasculature: Emerging role in health and disease. Mol Cell Endocrinol 2006; 252: 201-206 (Pubitemid 43914099)
2. Zhou Y, Wei E, Fang S, et al. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci 2006; 79: 1645-1656 (Pubitemid 44349150)
3. Chu L, Fang S, Zhou Y, et al. Minocycline inhibits 5-lipoxygenase activation and brain inflammation after focal cerebral ischemia in rats. Acta Pharmacol Sin 2007; 28: 763-772 (Pubitemid 46817443)
4. Ohtsuki T, Matsumoto M, Hayashi Y, et al. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol 1995; 268: 1249-1257
5. St-Pierre Y, Couillard J, van Themsche C. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets 2004; 8: 473-489 (Pubitemid 39359652)
6. Yong VW, Krekoski CA, Forsyth PA, et al. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 1998; 21: 75-80
7. Gasche Y, Fujimura M, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction. J Cereb Blood Flow Metab 1999; 19: 1020-1028 (Pubitemid 30173725)
8. Fujimura M, Gasche Y, Morita-Fujimura Y, et al. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res 1999; 842: 92-100 (Pubitemid 29447856)
9. Carter GW, Young PR, Albert DH, et al. 5-lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther 1991; 256: 929-937
10. Patel NSA, Cuzzocrea S, Chatterjee PK, et al. Reduction of renal ischemia-reperfusion injury in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. Mol Pharmacol 2004; 66: 220-227 (Pubitemid 38989478)
11. Ye YN, Wu WKK, Shin VY, et al. A mechanistic study of colon cancer growth promoted by cigarette smoke extract. Eur J Pharmacol 2005; 519: 52-57 (Pubitemid 43181164)
12. Cipollone F, Mezzetti A, Fazia ML, et al. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 2005; 25: 1665-1670 (Pubitemid 41098938)
13. Li Y, Xua Z, Ford GD, et al. Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia. Brain Res 2007; 1184: 277-283 (Pubitemid 350160568)
14. Lin TN, He YY, Wu G, et al. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993; 24: 117-121 (Pubitemid 23014393)
15. Asahi M, Asahi K, Jung JC, et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000; 20: 1681-1689
16. Lazarus SC, Lee T, Kemp JP, et al. Safety and clinical efficacy of zileuton in patients with chronic asthma. Am J Manag Care 1998; 4: 841-848 (Pubitemid 28375894)
17. Baskaya MK, Hu Y, Donaldson D, et al. Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia. J Neurosurg 1996; 85: 112-116 (Pubitemid 26195045)
18. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998; 29: 2189-2195
19. Jatana M, Giri S, Ansari MA, et al. Inhibition of NF-κB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflammation 2006; 3: 12 (Pubitemid 44192728)
20. Romanic AM, White RF, Arleth AJ, et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: Inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-1030
21. Collin M, Rossi A, Cuzzocrea S, et al. Reduction of the multiple organ injury and dysfunction caused by endotoxemia in 5-lipoxygenase knockout mice and by the 5-lipoxygenase inhibitor zileuton. J Leukoc Biol 2004; 76: 961-970 (Pubitemid 39458708)
22. Chen X, Wang S, Wu N, et al. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res 2004; 10: 6703-6709 (Pubitemid 39346568)
23. Xue M, Yong VW. Matrix metalloproteinases in intracerebral hemorrhage. Neurol Res 2008; 30: 775-782
24. Yong VW. The potential use of MMP inhibitors to treat CNS diseases. Exp Opin Investig Drugs 1999; 8: 255-268
25. Asahi M, Sumii T, Fini ME, et al. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 2001; 12: 3003-3007 (Pubitemid 32882025)